Please use this identifier to cite or link to this item:
|Title:||Temozolomide-associated liver fibrosis|
|Authors:||Parakh, Sagun;Hamid, Anis A;Cher, Lawrence M;Gan, Hui K|
|Affiliation:||Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia|
Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia
|Citation:||The Journal of Clinical Pharmacology 2016; 56(11): 1448-1449|
|Abstract:||Temozolomide is generally well tolerated and severe hepatic toxicities associated with temozolomide are rare. We report a case of liver fibrosis in a patient on temozolomide for the treatment of GBM. This article is protected by copyright. All rights reserved.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.